These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3325249)

  • 1. [Preliminary study on plasma 6-keto-prostaglandin F1 alpha levels before and after induction by furosemide in hypertensive patients].
    Zhao GS; Yuan XY; Shen XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Jun; 15(3):134-6, 190. PubMed ID: 3325249
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of furosemide stimulation on renin secretion and its application in examining activity of the renin-angiotensin system.
    Zofková I
    Cor Vasa; 1976; 18(4):304-9. PubMed ID: 1022409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of furosemide on angiotensin II-mediated prostaglandin I2 production in hypertensive subjects.
    Fujimura A; Ebihara A
    Eur J Clin Pharmacol; 1990; 39(2):113-5. PubMed ID: 2253658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of verapamil on renin-angiotensin-aldosterone system, urinary 6-keto prostaglandin F1 alpha and aldosterone response to metoclopramide in normal man.
    Zacharieva S; Koev D; Matrozov P; Tcharaktchiev D; Stoeva I; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):31-6. PubMed ID: 2634902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Responses of plasma bradykinin and the renin-angiotensin axis to furosemide in essential hypertension].
    Takeda Y; Miyamori I; Ikeda M; Koshida H; Yasuhara S; Nagai K; Morise T; Takimoto H; Takeda R
    Nihon Jinzo Gakkai Shi; 1985 Apr; 27(4):525-31. PubMed ID: 3897676
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basic and clinical studies of angiotensin II pressor responsiveness in pregnancy-induced-hypertension].
    Ito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):991-9. PubMed ID: 2855232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
    Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Christensen NJ; Giese J
    Acta Med Scand; 1979; 205(7):547-55. PubMed ID: 474180
    [No Abstract]   [Full Text] [Related]  

  • 9. [The renin-angiotensin-aldosterone system in essential arterial hypertension].
    Ruilope L; Alcazar JM; García Robles R; Gutiérrez Millet V; Jarillo MD; Torres J; Morales JM; Rodicio JL
    Rev Clin Esp; 1977 Sep; 146(5):233-7. PubMed ID: 928859
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of saralasin on the activity of the renin-angiotensin-aldosterone system, sympathetic-adrenal system and the level of the 6-keto-PGF1 alpha metabolite of prostacyclin in patients with primary arterial hypertension].
    Bar-Andziak E; Ignatowska-Switalska H; Wocial B; Kabat M; Makowiecka-Cieśla M; Cybulska I; Sznajderman M
    Kardiol Pol; 1985; 28(7):481-8. PubMed ID: 3910904
    [No Abstract]   [Full Text] [Related]  

  • 11. Responses of urinary 6-keto-prostaglandin F1 alpha to furosemide administration test in patients with essential hypertension.
    Watanabe Y; Honda M; Hatano M
    Nihon Jinzo Gakkai Shi; 1984 Sep; 26(9):1213-21. PubMed ID: 6392643
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension.
    Uehara Y; Ishii M; Ikeda T; Atarashi K; Takeda T; Murao S
    Prostaglandins Leukot Med; 1983 May; 11(1):95-104. PubMed ID: 6348803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension.
    Uehara Y; Ishii M; Ikeda T; Atarashi K; Takeda T; Murao S
    Prostaglandins Leukot Med; 1983 Apr; 10(4):455-64. PubMed ID: 6344103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive mechanisms in coarctation of the aorta. Further studies of the renin-angiotensin system.
    Parker FB; Farrell B; Streeten DH; Blackman MS; Sondheimer HM; Anderson GH
    J Thorac Cardiovasc Surg; 1980 Oct; 80(4):568-73. PubMed ID: 6999245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
    Zacharieva S; Koev D; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins, renin-angiotensin system, and hypertension.
    Nasjletti A; Baer PG
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():171-8. PubMed ID: 3159199
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma thromboxane B2 and 6-keto-prostaglandin F1-alpha concentrations in patients with essential and renovascular hypertension].
    Gong LS; Shen XY; Ding HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Feb; 14(1):23-5, 62-3. PubMed ID: 3755674
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of furosemide administration and upright position on plasma renin activity and angiotensin II in hypertension.
    Fukuchi S; Takenouchi T; Nakajima K
    Tohoku J Exp Med; 1973 Sep; 111(1):71-8. PubMed ID: 4359911
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
    Schmitt SL; Taylor K; Schmidt R; Van Orden D; Williamson HE
    J Pharmacol Exp Ther; 1981 Nov; 219(2):407-14. PubMed ID: 7026766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.